HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

diphtheria-tetanus-acellular pertussis-Hib-hepatitis B vaccine

Also Known As:
DTPa-HBV vaccine; DTaP-HBV; DTaP-PRP-T-HB combination vaccine; DTaP-PRP-T-HB vaccine; InfanrixHepB
Networked: 19 relevant articles (0 outcomes, 5 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Jacquet, Jeanne-Marie: 3 articles (04/2010 - 08/2006)
2. Rinderknecht, Stephen: 2 articles (02/2015 - 02/2015)
3. Baine, Yaela: 2 articles (02/2015 - 02/2015)
4. Miller, Jacqueline M: 2 articles (02/2015 - 02/2015)
5. Latiolais, Thomas: 2 articles (02/2015 - 02/2015)
6. Blatter, Mark: 2 articles (02/2015 - 02/2015)
7. Friedland, Leonard R: 2 articles (02/2015 - 02/2015)
8. Bianco, Veronique: 2 articles (02/2015 - 02/2015)
9. Simon, Michael: 2 articles (02/2015 - 02/2015)
10. Twiggs, Jerry: 2 articles (02/2015 - 02/2015)

Related Diseases

1. Tetanus
2. Whooping Cough (Pertussis)
3. Diphtheria
4. Hepatitis B
5. Poliomyelitis (Polio)
04/01/2010 - "After a birth dose of acellular pertussis (aP) and diphtheria (DT)aP-hepatitis B virus (HBV)-inactivated polio vaccine (IPV)/Haemophilus influenza type b (Hib) at 2, 4, and 6 months, a booster dose of DTaP-HBV-IPV/Hib at 12 to 23 months induced strong anti-pertussis booster responses. "
05/26/2009 - "Two scientific projects have been carried out, aimed: (i) to assess the immunogenicity of PCV-7 and of a hexavalent vaccine Diphtheria-Tetanus-Trivalent Acellular Pertussis-Hepatitis B-Inactivated Polio Virus-Haemophilus influenzae type B (DTaP-HBV-IPV-Hib) when co-administered to healthy infants at 3, 5 and 11-12 months of age (routine schedule), and (ii) to evaluate the effect of the immunisation campaign in preventing pneumococcal-associated hospitalisations. "
09/01/2000 - "The aim of this open, multicenter, randomized trial was to evaluate the immunogenicity and reactogenicity of a candidate combined diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio virus (DTaP-HBV-IPV) vaccine when given as either a mixed or as separate concomitant injections with Haemophilus influenzae type b (Hib) vaccine. "
01/01/2009 - "The aim of this study was to evaluate the immunogenicity and reactogenicity of two commercial diphtheria-tetanus- acellular pertussis-hepatitis b-inactivated polio virus-Haemophilus influenzae type b (DTaP-HBV-IPV/Hib) combination vaccines when administered to infants at 3, 5 and 11-12 months of age. "
06/01/2010 - "A total of 606 subjects were randomly assigned to receive either PCV13 or PCV7 at 3, 5, and 11 months of age; all subjects concomitantly received diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B (DTaP-HBV-IPV/Hib) vaccine. "

Related Drugs and Biologics

1. diphtheria-tetanus-acellular pertussis-Hib-hepatitis B vaccine
2. Hepatitis B Vaccines (Hepatitis B Vaccine)
3. Haemophilus influenzae type b polysaccharide vaccine (HIB-vaccine)
4. Combined Vaccines
5. Pentetic Acid (DTPA)
6. Antigens
7. Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (ActHIB)
8. Vaccines
9. Carbon Monoxide
10. MART-1 Antigen

Related Therapies and Procedures

1. Injections
2. Stents